Ví dụ về việc sử dụng Ebola vaccine trong Tiếng anh và bản dịch của chúng sang Tiếng việt
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
Experiment of Ebola vaccine.
Ebola vaccine may be available by 2015.
Experiment of Ebola vaccine.
Ebola vaccine is 97.5% effective.
How Does the Ebola Vaccine Work?
Ebola vaccine trial 100% successfully in Guinea.
The world finally has an Ebola vaccine.
A new Ebola vaccine is 100% effective.
Finally, the world has an Ebola vaccine.
Ebola vaccine is 100 percent effective in Guinea trial.
HHS to provide $23 million to Merck for Ebola vaccine production.
GSK Ebola vaccine update leading to many comments and shares;
These results don't mean that the world now has an Ebola vaccine.
The first batch of 4,000 Ebola vaccine doses arrived in the DRC capital of Kinshasa.
The Department of Defense isworking with a company called Newlink to develop an Ebola vaccine candidate.
Previous post Final trial results confirm Ebola vaccine provides high protection against disease.
The Department of Health and Human Services(HHS)is helping via $23 million funding towards Merck's Ebola vaccine production.
Oct 24,The World Health Organization said hundreds of thousands of Ebola vaccine doses could be rolled out to west Africa by the middle of next year.
GSK applied for regulatory approval in 2014 for the first malaria vaccine andcurrently has one of the leading candidates for an Ebola vaccine undergoing clinical trials.
There are seven other Ebola vaccines in various stages of clinical testing, according to the World Health Organization(WHO) in Geneva.
Europe is also set to provide 200million euros($250 million) of funding to develop new Ebola vaccines, as well as drugs and diagnostic tests.
It worked for the Ebola vaccine, and could work for the Zika vaccine, or any other emerging threat we might see.
Additionally, NIH andthe Thomas Jefferson University are collaborating to develop a candidate Ebola vaccine based on the established rabies vaccine. .
NNA- Researchers say they're a step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.
While there is no licensed vaccine to fight the Ebola virus, the World Health Organization(WHO)said the Ebola vaccine in question had performed well in a clinical trial in Guinea.
The economics of an Ebola vaccine are still unclear but drug companies with an eye on their reputations are under pressure to respond to the major international health crisis now ravaging one of the poorest corners of Africa.
They also support the Crucell biopharmaceutical company andtheir development of a Marburg/Ebola vaccine, plus Profectus Biosciences in their development of a vaccine for Ebola. .
Canadian scientist Gary Kobinger, a scientist who worked on the Ebola vaccine and part of a consortium working on a Zika vaccine, has revealed that the first stage of human testing could start in early August- meaning it could be ready by autumn 2016.
Canada's Minister of Health, Rona Ambrose, announced Monday the the launch ofPhase 1 clinical trials for Canada's Ebola vaccine(VSV-EBOV) at the Walter Reed Army Institute of Research in Silver….